Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2392183
Max Phase: Preclinical
Molecular Formula: C17H11BrN2O6
Molecular Weight: 419.19
Molecule Type: Small molecule
Associated Items:
ID: ALA2392183
Max Phase: Preclinical
Molecular Formula: C17H11BrN2O6
Molecular Weight: 419.19
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1
Standard InChI: InChI=1S/C17H11BrN2O6/c1-25-14-3-2-8(7-19-14)16(22)20-11-5-9(18)4-10-12(21)6-13(17(23)24)26-15(10)11/h2-7H,1H3,(H,20,22)(H,23,24)
Standard InChI Key: FFRLOXKAKNBOMY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 419.19 | Molecular Weight (Monoisotopic): 417.9800 | AlogP: 2.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 118.73 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 0.93 | CX Basic pKa: 2.52 | CX LogP: 1.01 | CX LogD: -1.15 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.67 | Np Likeness Score: -1.02 |
1. Funke M, Thimm D, Schiedel AC, Müller CE.. (2013) 8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35., 56 (12): [PMID:23713606] [10.1021/jm400587g] |
2. Thimm D, Funke M, Meyer A, Müller CE.. (2013) 6-Bromo-8-(4-[(3)H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic Acid: a powerful tool for studying orphan G protein-coupled receptor GPR35., 56 (17): [PMID:23888932] [10.1021/jm4009373] |
Source(1):